Donepezil: Clinical Trials

67 trials of Donepezil, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

55 completed, 5 terminated, 3 withdrawn, 2 unknown. 67 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 167Completed 55, Terminated 5, Withdrawn 3, Unknown 2, Active not recruiting 1, Not yet recruiting 1
Phase 23Active not recruiting 1, Completed 1, Withdrawn 1

Follow Donepezil: new trials by email Literature Review of Donepezil trials Research Report on Donepezil

Trials (filtered) newest first · largest first

All 67 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2511 in Participants With Early Alzheimer's Disease (AD)
E2511, Donepezil - Alzheimers Disease
Phase 1Not yet recruitingEisai Inc.322026-10-152026-08-17
Pharmacokinetic Study of GB-5001A 280 mg Long Acting Injection, in Comparison With the Comparator Drug Aricept® 5 mg and Aricept® 10 mg Film-coated Tablet in Healthy Subjects
GB-5001A 280 mg long acting Injection, Aricept® 5 mg film-coated tablet, Aricept® 10 mg film-coated tablet - Bioavailability Study on Healthy Volunteers
Phase 1CompletedG2GBio, Inc.282025-08-122026-09-02
Phenserine on the Alzheimer's Treatment Horizon, Study 1
Phenserine, Donepezil (Aricept®) - Alzheimer Disease, Mild Cognitive Impairment
Phase 1CompletedHelse Stavanger HF162025-02-012026-05-04
Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia Taking Stable Donepezil Treatment (MK-1167-007)
MK-1167, Donepezil, Placebo - Alzheimer's Disease
Phase 1CompletedMerck Sharp & Dohme LLC282024-03-282025-10-14
A Clinical Trial to Access Pharmacokinetic Profiles and Safety of IVL3003.
Aricept Tablet, IVL3003 - Alzheimer Disease
Phase 1 / Phase 2Active not recruitingInventage Lab., Inc.622023-04-012024-12-19
Phase 1 Clinical Trial of DA-5207 in Healthy Adults
Aricept 5mg Tablet, Aricept 10mg Tablet, DA-5207 A - Healthy
Phase 1CompletedDong-A ST Co., Ltd.512021-11-252023-04-14
Cognition Platform Study in Participants at Risk for Alzheimer's Disease (AD) (MK-0000-413)
Donepezil, Placebo - Alzheimer's Disease, Mild Cognitive Impairment
Phase 1CompletedMerck Sharp & Dohme LLC442021-03-232024-10-28
MK-1942/Donepezil Interactions in Participants With Alzheimer's Disease (MK-1942-005)
MK-1942, Donepezil, Placebo - Alzheimer's Disease
Phase 1CompletedMerck Sharp & Dohme LLC272021-02-162024-08-15
Pharmacokinetic Study of 5 and 10 mg Corplex™ Donepezil TDS Compared to 10 mg Aricept® in Healthy Volunteers
Donepezil TDS, Aricept - Healthy Subjects
Phase 1CompletedCorium, Inc.602020-12-082024-09-19
Phase 1 Clinical Trial to Evaluate the Safety, PK and PD of DA-5207 TDS in Healthy Adults
Aricept 5mg Tablet, Aricept 10mg Tablet, DA-5207 150mg - Healthy
Phase 1UnknownDong-A ST Co., Ltd.492020-07-282021-04-15
Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005)
MK-4334, Placebo to MK-4334, Donepepzil - Alzheimer's Disease, Mild Cognitive Impairment
Phase 1WithdrawnMerck Sharp & Dohme LLC2019-09-272025-04-25
Safety and Pharmacokinetic of Donepezil Pamoate in Healthy Subjects
Donepezil Pamoate for Injection 17mg, Donepezil Pamoate for Injection 34mg, Donepezil Hydrochloride 5mg - AD
Phase 1CompletedShanghai Synergy Pharmaceutical Sciences Co., Ltd.382019-07-022020-09-29
Single-ascending Dose Phase 1 Clinical Trial to Evaluate the Safety and PK of DA-5207 TDS in Healthy Adults
DA-5207, Donepezil Hydrochloride - Healthy
Phase 1CompletedDong-A ST Co., Ltd.402019-06-182021-04-14
A Study in Healthy Men and Women to Test Which Effects Donepezil and BI 425809 Have on Each Other
BI 425809, Donepezil - Healthy
Phase 1CompletedBoehringer Ingelheim322019-04-122021-02-17
A FDG-PET Study of AGN-242071 Added to Standard-of-Care (Donepezil ± Memantine) for the Treatment of Participants With Mild to Moderate Alzheimer's Disease
AGN-242071, Placebo, Donepezil - Alzheimer's Disease
Phase 1WithdrawnAllergan2018-09-302018-11-02
A Pharmacodynamics, Safety, and Pharmacokinetics Study of THN201 Versus Donepezil in Healthy Male Volunteers
THN 201, Donepezil, Placebo - Cognitive Impairment, Alzheimer Disease
Phase 1CompletedTheranexus1522018-09-272020-01-22
CKD-355 Drug-drug Interaction Study (CKD-355 DDI P1)
Memantine Tab. 10mg, Memantine Tab. 10mg + Donepezil Tab. 10mg - Central Nervous System Diseases
Phase 1CompletedChong Kun Dang Pharmaceutical202018-04-162018-06-26
A Bioequivalence Study of Corplex™ Donepezil Transdermal Delivery System Compared to Aricept®
Donepezil TDS, Aricept - Alzheimer's Disease
Phase 1CompletedCorium, Inc.862017-10-302018-08-01
Study to Evaluate the Effects of BPN14770 on Scopolamine-induced Cognitive Impairment in Healthy Volunteers
BPN14770, BPN14770 placebo, Donepezil - Alzheimer Disease
Phase 1CompletedTetra Discovery Partners382017-01-012018-10-16
TAK-071 Scopolamine-Induced Cognitive Impairment Study
Scopolamine, TAK-071, Donepezil - Healthy Volunteers
Phase 1TerminatedTakeda182016-11-212019-06-14

Showing 20 of 67. Sign in to see all of them.

Conditions studied

Alzheimer Disease (27)  ·  Cognitive Dysfunction (8)  ·  Dementia (4)  ·  Memory Disorders (3)  ·  Central Nervous System Diseases (2)  ·  Stroke (2)  ·  Amblyopia (1)  ·  Autism Spectrum Disorder (1)  ·  Autistic Disorder (1)  ·  Brain Neoplasms (1)  ·  Central Nervous System Neoplasms (1)  ·  Cognition Disorders (1)  ·  Dementia, Vascular (1)  ·  Fragile X Syndrome (1)  ·  Hyperalgesia (1)

Sponsors

Merck Sharp & Dohme LLC (8)  ·  AstraZeneca (4)  ·  Dr. Reddy's Laboratories Limited (4)  ·  Teva Pharmaceuticals USA (4)  ·  Corium, Inc. (3)  ·  Dong-A ST Co., Ltd. (3)  ·  Eisai Co., Ltd. (3)  ·  Boehringer Ingelheim (2)  ·  Eisai Inc. (2)  ·  Pfizer (2)  ·  Ranbaxy Laboratories Limited (2)  ·  Takeda (2)  ·  Wyeth is now a wholly owned subsidiary of Pfizer (2)  ·  Allergan (1)  ·  Boston Children's Hospital (1)

Countries

United States (26)  ·  France (8)  ·  South Korea (7)  ·  Canada (4)  ·  United Kingdom (4)  ·  Japan (3)  ·  Australia (2)  ·  Germany (2)  ·  India (2)  ·  China (1)  ·  Indonesia (1)  ·  Netherlands (1)  ·  Norway (1)

Top investigators

Benoit J Deschamps, M.D. (2)  ·  Danielle Armas, MD (2)  ·  Dr. L Krishna Murthy (2)  ·  Eric Sicard, MD (2)  ·  Hiroki Shimizu (2)  ·  James D Carlson, Pharm.D. (2)  ·  A. M. Barrett, MD (1)  ·  Allan L Reiss (1)  ·  Beth Safirstein, M.D. (1)  ·  Bharti Gangwani, MD (1)

Results publications

PMID 21644059, PMID 21723605, PMID 25218827, PMID 36120781

NIH funding

2015 (1), 2018 (1)